FFCP PHASE2:Hg19::chr12:133263893..133263986,-
From FANTOM5_SSTAR
Jump to: navigation, search
Short description: | p1@POLE |
---|---|
Species: | Human (Homo sapiens) |
DPI dataset: | Robust |
TSS-like-by-RIKEN-classifier(Yes/No): | Yes |
DHS support(Yes/No): | Yes |
Description: | CAGE_peak_1_at_POLE_5end |
Coexpression cluster: | C1011_acute_granulocyte_Hodgkin_neuroepithelioma_retinoblastoma_hepatoblastoma_merkel |
Association with transcript: | 0bp_to_ENST00000320574, ENST00000376577, ENST00000535270, ENST00000537064, ENST00000539357, NM_006231, uc001uks.1, uc009zyu.1, uc010tbq.1_5end |
EntrezGene: | POLE |
HGNC: | 9177 |
UniProt: | Q07864E7ENR1F5H1D6F5H7E4Q59EA9 |
Genome view: | ZENBU |
View on UCSC genome browser
CAGE Expression
Sample | p1@POLE |
---|
0
50
100
150
200
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
cancer | 2.39e-37 | 235 |
disease of cellular proliferation | 3.49e-35 | 239 |
hematologic cancer | 1.16e-21 | 51 |
immune system cancer | 1.16e-21 | 51 |
organ system cancer | 2.94e-21 | 137 |
cell type cancer | 6.84e-20 | 143 |
leukemia | 2.33e-19 | 39 |
carcinoma | 5.89e-17 | 106 |
myeloid leukemia | 3.68e-16 | 31 |
Showing 1 to 9 of 9 entries